"Sulfones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D013450
|
MeSH Number(s) |
D02.886.590
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sulfones".
Below are MeSH descriptors whose meaning is more specific than "Sulfones".
This graph shows the total number of publications written about "Sulfones" by people in this website by year, and whether "Sulfones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2020 | 1 | 1 | 2 |
2021 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sulfones" by people in Profiles.
-
Development of Rofecoxib-Based Fluorophores from ACQ to AIE by Positional Regioisomerization. Chempluschem. 2022 Apr; 87(4):e202100522.
-
Development of Rofecoxib-Based Fluorescent Probes and Investigations on Their Solvatochromism, AIE Activity, Mechanochromism, and COX-2-Targeted Bioimaging. Anal Chem. 2021 09 07; 93(35):11991-12000.
-
One-Step Transformation from Rofecoxib to a COX-2 NIR Probe for Human Cancer Tissue/Organoid Targeted Bioimaging. ACS Appl Bio Mater. 2021 03 15; 4(3):2723-2731.
-
Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082. Int J Mol Sci. 2020 Sep 28; 21(19).
-
NF-?B inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-?B(p65) and actin cytoskeleton regulatory pathways. Sci Rep. 2020 08 07; 10(1):13352.